(Q43680779)

25 November 2017

title

Impaired glucose metabolism predicts mortality after a myocardial infarction (English)

1 reference

ORCID Public Data File 2021

25 November 2017

main subject

myocardial infarction

1 reference

1 reference

author name string

Bolk J

1

1 reference

25 November 2017

van der Ploeg T

2

1 reference

25 November 2017

Cornel JH

3

1 reference

25 November 2017

Arnold AE

4

1 reference

25 November 2017

Sepers J

5

1 reference

25 November 2017

Umans VA

6

1 reference

25 November 2017

language of work or name

English

0 references

publication date

1 July 2001

1 reference

International Journal of Cardiology

25 November 2017

published in

1 reference

25 November 2017

volume

79

1 reference

25 November 2017

issue

2-3

1 reference

25 November 2017

page(s)

207-214

1 reference

Metabolic Control and Prevalent Cardiovascular Disease in Non-Insulin-dependent Diabetes Mellitus (NIDDM): The NIDDM Patient Outcomes Research Team

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2801%2900422-3

7 January 2021

Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2801%2900422-3

7 January 2021

Impact of diabetes on mortality after the first myocardial infarction. The FINMONICA Myocardial Infarction Register Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2801%2900422-3

7 January 2021

Mechanisms determining course and outcome of diabetic patients who have had acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2801%2900422-3

7 January 2021

Outcome of patients with diabetes mellitus and acute myocardial infarction treated with thrombolytic agents. The Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2801%2900422-3

7 January 2021

Residual left ventricular pump function after acute myocardial infarction in NIDDM patients

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2801%2900422-3

7 January 2021

Clinical course of myocardial infarction among diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2801%2900422-3

7 January 2021

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2801%2900422-3

7 January 2021

Prevalence and mortality of acute myocardial infarction in patients with diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2801%2900422-3

7 January 2021

Myocardial infarction in patients with diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2801%2900422-3

7 January 2021

Prevalence and risks of hyperglycaemia and undiagnosed diabetes in patients with acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2801%2900422-3

7 January 2021

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2801%2900422-3

7 January 2021

Tailored thrombolytic therapy. A perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2801%2900422-3

7 January 2021

Stress hyperglycaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2801%2900422-3

7 January 2021

Hyperglycemia during physical stress

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2801%2900422-3

7 January 2021

Effects of glucose and fatty acids on myocardial ischaemia and arrhythmias

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2801%2900422-3

7 January 2021

Initial metabolic and hormonal response to acute myocardial infarction.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2801%2900422-3

7 January 2021

Glucose-insulin-potassium therapy for treatment of acute myocardial infarction: an overview of randomized placebo-controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2801%2900422-3

7 January 2021

Hyperglycemia and prognosis of acute myocardial infarction in patients without diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2801%2900422-3

7 January 2021

Effects of acute hyperglycaemia on cardiac function: an echocardiographic study of monozygotic twins

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2801%2900422-3

7 January 2021

Banting lecture 1988. Role of insulin resistance in human disease

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2801%2900422-3

7 January 2021

Hyperinsulinemia predicts coronary heart disease risk in healthy middle-aged men: the 22-year follow-up results of the Helsinki Policemen Study

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2801%2900422-3

7 January 2021

Relationship of glucose and insulin levels to the risk of myocardial infarction: a case-control study.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2801%2900422-3

7 January 2021

Prognostic significance of diabetes in acute myocardial infarction. Are the differences linked to female gender?

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2801%2900422-3

7 January 2021

Cardiovascular risk factors in confirmed prediabetic individuals. Does the clock for coronary heart disease start ticking before the onset of clinical diabetes?

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2801%2900422-3

7 January 2021

Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2801%2900422-3

7 January 2021

Effects of insulin treatment on cause-specific one-year mortality and morbidity in diabetic patients with acute myocardial infarction. DIGAMI Study Group. Diabetes Insulin-Glucose in Acute Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2801%2900422-3

7 January 2021

Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2801%2900422-3

7 January 2021

Metabolic modulation of acute myocardial infarction. The ECLA (Estudios Cardiológicos Latinoamérica) Collaborative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2801%2900422-3

7 January 2021

10.1016/S0167-5273(01)00422-3

Identifiers

DOI

1 reference

release_j5rlmyx5ffgz7j3dj3qizern2y

25 November 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/j5rlmyx5ffgz7j3dj3qizern2y

24 November 2022

mapped directly with Wikidata item

1 reference